LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Depreciation, Depletion and Amortization in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Lifecore Biomedical, Inc. \De\ quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q3 2010 to Q3 2024.
  • Lifecore Biomedical, Inc. \De\ Depreciation, Depletion and Amortization for the quarter ending August 25, 2024 was $1.99M, a 8.07% decline year-over-year.
  • Lifecore Biomedical, Inc. \De\ annual Depreciation, Depletion and Amortization for 2023 was $8.86M, a 32.8% decline from 2022.
  • Lifecore Biomedical, Inc. \De\ annual Depreciation, Depletion and Amortization for 2022 was $13.2M, a 27% decline from 2021.
  • Lifecore Biomedical, Inc. \De\ annual Depreciation, Depletion and Amortization for 2021 was $18.1M, a 9.09% decline from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.99M -$175K -8.07% May 27, 2024 Aug 25, 2024 10-Q 2024-10-04
Q3 2023 $2.17M -$2.19M -50.2% May 29, 2023 Aug 27, 2023 10-Q 2024-10-04
Q3 2022 $4.35M -$711K -14% May 30, 2022 Aug 28, 2022 10-Q 2024-08-09
Q3 2021 $5.07M -$37K -0.73% May 31, 2021 Aug 29, 2021 10-K 2024-03-20
Q3 2020 $5.1M +$599K +13.3% Jun 1, 2020 Aug 30, 2020 10-K 2024-03-20
Q3 2019 $16.6M $4.5M +$1.36M +43.2% May 27, 2019 Aug 25, 2019 10-Q 2020-10-07
Q2 2019 $15.2M $4.72M +$1.39M +41.6% Feb 25, 2019 May 26, 2019 10-K 2021-07-29
Q1 2019 $13.8M $4.05M +$906K +28.8% Nov 26, 2018 Feb 24, 2019 10-Q 2019-04-04
Q4 2018 $12.9M $3.31M +$333K +11.2% Aug 27, 2018 Nov 25, 2018 10-Q 2019-01-07
Q3 2018 $12.6M $3.15M +$191K +6.47% May 28, 2018 Aug 26, 2018 10-Q 2019-10-03
Q2 2018 $12.4M $3.34M +$476K +16.6% Feb 26, 2018 May 27, 2018 10-K 2020-08-14
Q1 2018 $11.9M $3.14M +$425K +15.6% Nov 27, 2017 Feb 25, 2018 10-Q 2019-04-04
Q4 2017 $11.5M $2.98M +$430K +16.9% Aug 28, 2017 Nov 26, 2017 10-Q 2019-01-07
Q3 2017 $11.1M $2.95M +$404K +15.8% May 29, 2017 Aug 27, 2017 10-Q 2018-10-05
Q2 2017 $10.7M $2.86M -$49K -1.68% Feb 27, 2017 May 28, 2017 10-K 2019-08-01
Q1 2017 $10.7M $2.72M +$570K +26.5% Nov 28, 2016 Feb 26, 2017 10-Q 2018-04-05
Q4 2016 $10.2M $2.55M +$422K +19.8% Aug 29, 2016 Nov 27, 2016 10-Q 2018-01-05
Q3 2016 $9.73M $2.55M +$339K +15.3% May 30, 2016 Aug 28, 2016 10-Q 2017-09-28
Q2 2016 $9.4M $2.91M +$996K +52.1% Feb 29, 2016 May 29, 2016 10-K 2018-08-09
Q1 2016 $8.4M $2.15M +$313K +17.1% Nov 30, 2015 Feb 28, 2016 10-Q 2017-04-07
Q4 2015 $8.09M $2.13M +$298K +16.3% Aug 31, 2015 Nov 29, 2015 10-Q 2017-01-05
Q3 2015 $7.79M $2.21M +$698K +46.1% Jun 1, 2015 Aug 30, 2015 10-Q 2016-09-29
Q2 2015 $7.09M $1.91M +$163K +9.31% Mar 2, 2015 May 31, 2015 10-K/A 2018-03-15
Q1 2015 $6.93M $1.83M +$257K +16.3% Dec 1, 2014 Mar 1, 2015 10-Q 2016-03-30
Q4 2014 $6.67M $1.83M -$115K -5.91% Sep 1, 2014 Nov 30, 2014 10-Q 2016-01-07
Q3 2014 $6.79M $1.51M -$329K -17.9% Jun 2, 2014 Aug 31, 2014 10-Q 2015-10-01
Q2 2014 $7.11M $1.75M Feb 24, 2014 May 25, 2014 10-K 2016-08-01
Q1 2014 $1.58M Nov 25, 2013 Feb 23, 2014 10-Q 2015-04-02
Q4 2013 $1.95M Aug 26, 2013 Nov 24, 2013 10-Q 2015-01-09
Q3 2013 $1.84M -$14K -0.75% May 27, 2013 Aug 25, 2013 10-Q 2014-10-08
Q3 2012 $1.86M +$501K +37% May 28, 2012 Aug 26, 2012 10-Q 2013-09-26
Q3 2011 $1.36M +$49K +3.75% May 30, 2011 Aug 28, 2011 10-Q/A 2013-01-02
Q3 2010 $1.31M Jun 1, 2010 Aug 29, 2010 10-Q 2011-10-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.